EGFR-TKI Resistant Mutation

Known as: EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance, EGFR Tyrosine Kinase Inhibitor Resistant Mutation 
A molecular genetic abnormality indicating the presence of resistance in the epidermal growth factor receptor-tyrosine kinase inhibitor domain, due… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2018
012320122018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Multiple randomized clinical trials have demonstrated that epidermal growth factor receptor (EGFR) exon 19 deletion (19Del) and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2017
2017
Over the past decade, the advent of tyrosine kinase inhibitors (TKIs) has revolutionized the management of patients with non… (More)
  • table 1
Is this relevant?
Review
2016
Review
2016
INTRODUCTION While epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitors (TKIs) lead to longer progression-free… (More)
  • table 1
Is this relevant?
2016
2016
F Das 10 Jahres-Überleben für Patienten mit Chronisch Myeloischer Leukämie (CML) beträgt heute 83 Prozent. Patienten, die in… (More)
Is this relevant?
2016
2016
Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) readministration to lung cancer patients is common owing… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table 1
Is this relevant?
Review
2014
Review
2014
The mammalian target of rapamycin inhibitor (mTORI) everolimus and the tyrosine kinase inhibitor (TKI) axitinib are the only two… (More)
Is this relevant?
2013
2013
In den letzten Jahren ist die Bedeutung der peroral applizierbaren, zielgerichtet wirksamen Tumortherapeutika – allen voran die… (More)
Is this relevant?
Review
2012
Review
2012
PURPOSE To compare the efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitor monotherapy (EFGR-TKIs… (More)
Is this relevant?
Review
2012
Review
2012
Gastrointestinale Stromatumoren (GIST) sind die häufigsten mesenchymalen Tumoren des Gastrointestinaltrakts. Sie tragen in bis zu… (More)
Is this relevant?
2012
2012
Second-generation tyrosine kinase inhibitors (2G-TKIs) are effective at inducing complete cytogenetic responses (CCyRs) in… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?